Skip to main content
| News

Aging: The Tsunami for Healthcare

27.02.2019

Humanity is growing older. According to the UN the number of people in the world aged 60 years or over is projected to double to 2.1 billion by 2050. In developed countries, more than one third of the population will be over 60 by this time. The number of people over 80 will increase even faster to 434 million from 125 million in 2017. Meanwhile the working age population, who are needed to pay or provide support for the elderly, will only increase by about 25 percent over the same time.

From the left side: Thomas Brenzikofer (DayOne/ BaselArea.swiss), Szofia Bullain (MD Geriatric Neurologist), Antonella Santuccione (Woman’s Brain Project and Roche Diagnostics), Hansruedi Voelkle (EUPATI), Manfred Eggersdorfer, (DSM Nutritional Products), Andy Bushell (Novartis), Mieke Deschodt (University of Basel)

These numbers make clear: The question mark in the title of the DayOne Experts Event “Aging – the game changer for healthcare?” is actually redundant. The game simply has to be changed! The speakers and panelists at the event that took place in Basel on February 26 agreed that healthcare as we know it will not be able to cope with the tsunami of aging. Under this perspective, aging not only represents a threat, but also an opportunity, for it will compel the industry to make the systematic changes that are required for the overall improvement of healthcare. Therefore aging can and should also be perceived as an interesting market for healthcare innovation.

But where to begin? This is what we learned from the speakers and panelists at the DayOne Expert Event:

1) Healthcare as we know it has been built for acute care: from infrastructure to career plans, research incentives and reimbursement schemes, healthcare professionals are trained to fix and rescue lives. But when it comes to long-term care and treatment this acute system is highly inefficient and costly. A possible way forward was presented by Mieke Deschodt from the University of Basel, who presented the novel care concept INSPIRE, which will be implemented in the canton of Baselland.

2) A big research effort is needed to better diagnose, treat and most of all prevent the disease burdens of an aging population. As Antonella Santuccione from the Woman’s Brain Project stated: It takes weeks to diagnose a tumor, but years to diagnose Alzheimer’s. And the significant differences in disease progression in terms of gender shows that a precision medicine approach is very much needed to make progress in treating disorders that are typical to aging.

3) The best way to cope with the tsunami of aging is actually by staying healthy – not only as long as possible but preferably to the end of life. In this perspective, we have to shift our mindset from neglecting or avoiding aging to aging successfully. And as the findings of the 90+ Study show, presented by geriatric neurologist Szofia Bullain, this will need a more holistic view on health, as psychological and social implications seem to count much more than physical activities and healthy nutrition alone for successful aging.

4) The right use and bold implementation of technology, most of all digital technology, will be crucial. But a lifelong approach will also be needed. Knowing the genetic preposition would allow for better monitoring and nudging an individual to healthy behavior, thereby preventing the occurrence of disease in old age starting from the very beginning of our lifespan. But to actually make this happen a first important step will be to set up a trusted platform which allows citizens to share their health data with all stakeholders.

A big thank you to all the speakers and panelists for sharing their great stories and very valuable insights:

Mieke Deschodt, University of Basel
Antonella Santuccione, Woman’s Brain Project and Roche Diagnostic
Szofia Bullain, MD Geriatric Neurologist
Manfred Eggersdorfer, DSM Nutritional Products
Andy Bushell, Novartis
Hansruedi Voelkle, EUPATI

Impressions

Slides presented at the Event

Presentation by Antonella Santuccione from Woman’s Brain Project and Roche Diagnostic

Presentation by Mieke Deschodt from the University of Basel

Presentatio by Szofia Bullain from MD Geriatric Neurologist

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

BSI integrating AI from Parashift in banking software

Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest

UptownBasel joins IBM Quantum Network

UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
1 2 3 36

Do you have a question? We'd like to hear from you.